Keith Regnante Email & Phone Number

Chief Financial Officer @ Keros Therapeutics

View Keith's Email & Phone Number

5 free lookup(s). No credit card required.

If you need more lookups, subscriptions start at $34 USD/month.

Keith Regnante Location

Andover, MA, US

Keith Regnante Work

Chief Financial Officer @ (February 2020 - Present)
Chief Financial Officer @ (August 2016 - January 2020)
Vice President Finance @ (February 2014 - August 2016)
Head Research and Development and Manufacturing Finance @ Ariad Pharmaceuticals, Inc. (September 2013 - February 2014)
Senior Director, Corporate Finance @ (January 2011 - September 2013)
Senior Director Research and Development Finance @ (January 2008 - January 2011)
Director of Finance and Investor Relations @ (January 2007 - January 2008)
Director Research and Development Business Planning @ (January 2004 - January 2007)
Associate Director of Finance @ (January 2001 - January 2007)
Manager of Financial Planning @ (January 1999 - January 2001)
Consultant @ (September 1996 - December 1998)

Keith Regnante Education

Master of Business Administration
1996
Master of Business Administration
1994-1996
Tufts University
Bachelor of Arts (Economics)
1987-1991

Keith Regnante Skills

Acquisition Integration
Analysis
Biotechnology
Business Planning
Corporate Finance
Cross-functional Team Leadership
Finance
Financial Planning
Leadership
Management
Management Consulting
Mergers
Mergers & Acquisitions
Pharmaceutical Industry
Portfolio Management
Sarbanes-Oxley Act
Strategic Financial Planning
Strategy
Valuation
Fibrosis
Capital Structure
Variance Analysis
Consulting
Outline
Payments
Insurance
Expenses
Cost Accounting
Sales
Competitive Dynamics
Community
Concentrations
Cost
Primary Focus
Devising
Elan
Investor Relations
Proxy
Co Pa
Savings
Cross Functional Team Leadership
Clinical Development
Treatment
Procurement
Real Estate Transactions
Diagnose
Insurance Planning
ALM
Calls
HIT
Long Range
Sensitivity
Resolve
Auditing
Boston
Accounting
Big 4
Financials
Co Development
Sell Side
Networking
Forecasting
Legal Writing
Key Metrics
Team Management
In Licensing
Reports
Organizational Restructuring
Account Reconciliation
Variety of Industries
Strategies
Budgeting
Diligent
Risk Management
Training
Financial Institutions
Monthly Close
Conferences
Shareholder
Reporting
Close Process
Shares
R&d
Cost Reduction
Advertising Agency
P&l
Business Partnering
Manage Budgets
Financial Responsibilities
Growth Initiatives
Channel Strategy
Assumptions
Economics
C
Multi Product
Rights
Debt
Share Repurchase
Preparedness
Neurological Disorders
Business Development
Communication
Negotiation
Strategic Planning
Licensing
Stage
Values
Contingent
Competitive Advantage
Marketing
Executive Team
Pipelines
Project Planning
Project
Sarbanes Oxley Act
Golang
Contractual Agreements
Strategic Financial
Indications
Shareholder Activism
Shareholder Value
Distribution
International
Art
Intelligence
Kpmg
Efficient
Executive Management
Sustainable Growth
Collaborating
Portfolio
Board Presentations
Tax
Coordinate
Investments
Discovering
Buy Side
Compliance
Roadshows
Professional Services
Pharmaceutics
Project Accounting
Manufacturing
Asset
Global R&d
Therapeutic Area
Phi Beta Kappa
Treasury
Budgets
Business Strategy
Strategic Consulting
Optimization
Due Diligence
Deal Structures
Mergers and Acquisitions
Conclusions

Keith Regnante Summary

Keith Regnante, based in Andover, MA, US, is currently a Chief Financial Officer at Keros Therapeutics. Keith Regnante brings experience from previous roles at Wave Life Sciences, Shire, Ariad Pharmaceuticals, Inc. and Biogen. Keith Regnante holds a Master of Business Administration. With a robust skill set that includes Acquisition Integration, Analysis, Biotechnology, Business Planning, Corporate Finance and more. Keith Regnante has 3 emails and 3 mobile phone numbers on RocketReach.

Looking for a different Keith Regnante?

Find contact details for 700 million professionals.

Search

G2 Crowd Trusted

300K+ Plugin Users

products

information

teams

company